Problems with medicine use in older Australians: A review of recent literature

Journal of Pharmacy Practice and Research

Volumn 44, Issue 4, 2014, Pages 258-271

  Elliott, Rohan A ^a,b   Booth, Jane C ^a  

^a AUSTIN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; AUSTRALIAN; DRUG DOSE; DRUG INTERACTION; DRUG USE; ELECTRONIC PRESCRIBING; HOME CARE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICATION THERAPY MANAGEMENT; PHARMACIST; POLYPHARMACY; PREVALENCE; SYSTEMATIC REVIEW; TREATMENT REFUSAL;

EID: 84928742244     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr.1041     Document Type: Article

References (120)

1. Elliott RA. Problems with medication use in the elderly: an Australian perspective. J Pharm Pmct Res 2006; 36: 58-66.
2. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 2012; 28: 173-86.
3. Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med ] Ausl 2012; 196: 50-3.
4. Lee CY, George J, Elliott RA, Stewart K. Prevalence of medication-related risk factors among retirement village residents: a cross-sectional survey. Age Ageing 2010; 39: 581-7.
5. Roughead EE, Gilbert AL, Woodward MC. Medication use by Australian war veterans in residential aged-care facilities. J Pharm Pmct Res 2008; 38:14-8.
6. Somers M, Rose E, Simmonds D, Whitelaw C, Calver J, Beer C. Quality use of medicines in residential aged care. Aust Finn Physician 2010; 39:413-16.
7. Stafford AC, Alswayan MS, Tenni PC. Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther 2011; 36: 33-14.
8. Kaur S, Roberts JA, Roberts MS. Evaluation of medication-related problems in medication reviews: a comparative perspective. Ann Pharmacother 2012; 46: 972-82.
9. Khalil H. A review of pharmacist recommendations in an aged care facility. Ausl I Prim Health 2011; 17: 35-9.
10. Basger BJ, Chen TF, Moles RJ. Application of a prescribing indicators tool to assist in identifying drug-related problems in a cohort of older Australians. Int J Pharm Pract 2012; 20: 172-82.
11. Tran T, Elliott RA, Taylor SE, Woodward MC. A self-administration of medications program to identify and address potential barriers to adherence in elderly patients. Ann Pharmacother 2011; 45: 201-6.
12. Lam P, Elliott RA, George J. Impact of a self-administration of medications programme on elderly inpatients' competence to manage medications: a pilot study. J Clin Pharm Ther 2011; 36: 80-6.
13. Wahab MSA, Nyfort-Hansen K, Kowalski SR. Inappropriate prescribing in hospitalised Australian elderly as determined by the STOPP criteria, Int J Clin Pluirm 2012; 1-8.
14. Elliott RA, O'Callaghan CJ. Impact of hospitalisation on the complexity of older patients' medication regimens and potential for regimen simplification. J Pharm Pract Res 2011; 41: 21-5.
15. Bell JS, Whitehead P, Aslani P, McUichlan AJ, Chen TF. Drug-related problems in the community setting: pharmacists' findings andrecommendations for people with mental illnesses. Clin Drug Invest 2006; 26: 415-25.
16. Lowthian JA, Diug BO, Evans SM, Maxwell EL, Street AM, Piterman L, el al. Who is responsible for the care of patients treated with warfarin therapy? Med J Aust 2009; 190: 674-7.
17. Boyce L, Knight A. Audit of general practitioner medication lists for older patients at a regional hospital. J Pharm Pract Res 2013; 43:105-8.
18. Vasileff HM, Whitten LE, Pink JA, Goldsworthy SJ, Angley MT. The effect on medication errors of pharmacists charting medication in an emergency department. Plinnn World Sci 2009; 31: 373-9.
19. Ellitt GR, Engblom E, Aslani P, Westerlund T, Chen TF. Drug related problems after discharge from an Australian teaching hospital. Pharm World Sci 2010; 32: 622-30.
20. Elliott RA, Woodward MC. Medication-related problems in patients referred to aged care and memory clinics at a tertiary care hospital. Australas J Ageing 2011; 30: 124-9.
21. Elliott RA, Martinac G, Campbell S, Thorn J, Woodward MC. Pharmacist-led medication review to identify medication-related problems in older people referred to an Aged Care Assessment Team: a randomized comparative study. Drugs Aging 2012; 29: 593-605.
22. Mueller SK, Sponsler KC, Kripalani S, Schnipper JL. Hospital-based medicabon reconciliation practices: a systematic review. Arch Intern Med 2012; 172:1057-69.
23. Callen J, Mcintosh J, Li J. Accuracy of medication documentation in hospital discharge summaries: a retrospective analysis of medication transcription errors in manual and electronic discharge summaries, bit J Med Inform 2010; 79: 58-64.
24. Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 2007; 297: 831-41.
25. Boockvar KS, Livote EE, Goldstein N, Nebeker JR, Siu A, Fried T. Electronic health records and adverse drug events after patient transfer. Qual Saf Health Care 2010; 19: el6.
26. Elliott RA, Tran T, Taylor SE, Harvey PA, Belfrage MK, Jennings RJ, et al. Gaps in continuity of medication management during the transition from hospital to residential care: an observational study (MedGap Study). Australas ] Ageing 2012; 31: 247-54.
27. Harvey PA, Jennings R, Carter L, Elliott RA. Audit of medication management after discharge from hospital to residential care. J Pharm Pract Res 2012; 42: 246-7.
28. Pierce D, Fraser G. An investigation of medication information transfer and application in aged care facilities in an Australian rural setting. Rural Remote Health 2009; 9: 1090.
29. Elliott RA, Stehlik P. Identifying inappropriate prescribing for older people. J Pharm Pract Res 2013; 43: 312-19.
30. Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 2011; 71: 592-9.
31. Castelino RL, Hilmer SN, Bajorek BV, Nishtala P, Chen TF. Drug Burden Index and potentially inappropriate medications in community-dwelling older people: the impact of Home Medicines Review. Drugs Aging 2010; 27:135-48.
32. Caughey GE, Roughead EE, Vitry Al, McDermott RA, Shakib S, Gilbert AL. Comorbidity in the elderly with diabetes: Identificabon of areas of potential treatment conflicts. Diabetes Res Clin Pract 2010; 87: 385-93.
33. Curtain CM, Bindoff IK, Westbury JL, Peterson GM. A comparison of prescribing criteria when applied to older community-based patients. Drugs Aging 2013; 30: 935-43.
34. King MA, Roberts MS. The influence of the Pharmaceutical Benefits Scheme (PBS) on inappropriate prescribing in Australian nursing homes. Pharm World Sci 2007; 29: 39-42.
35. Pattanaworasate W, Emmerton L, Pulver L, Winckel K. Comparison of prescribing criteria in hospitalised Australian elderly. Pharm Pract 2010; 8:132-8.
36. Roughead EE, Anderson B, Gilbert AL. Potentially inappropriate prescribing among Australian veterans and war widows/widowers. Intern Med J 2007; 37: 402-5.
37. Widagdo IS, Nyfort-Hansen K, Kowalski SR. Prevalence of potentially inappropriate medication use in elderly hospitalised patients. J Pharm Pract Res 2011; 41:122-5.
38. Gnjidic D, Cumming RG, Le Cotiteur DG, Handelsman DJ, Naganathan V, Abernethy DR, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009; 68:97-105.
39. Ball P, Moririssey H, Pilotto L. Anticholinergic burden assessed using general practice electronic records. J Pharm Pract Res 2013; 43: 202-5.
40. Hollingworth SA, Siskind DJ. Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiol Drug Saf 2010; 19: 280-8.
41. Ilollingworth SA, Siskind DJ, Nissen LM, Robinson M, Hall WD. Patterns of antipsychotic medication use in Australia 2002-2007. Aust NZI Psychiatry 2010; 44: 372-7.
42. Blogg LC, Suzuki N, Roberts M, Clifford RM. Prescribing benzodiazepines in residential aged-care facilities. J Pharm Pract Res 2012; 42: 287-90.
43. Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR. Seibel MJ, et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011; 59: 875-80.
44. Wilson NM, Hilmer SN, March LM, Cameron ID, Lord SR, Seibel MJ, et al. Associations between drug burden index and physical function in older people in residential aged care facilities. Age Ageing 2010; 39: 503-7.
45. Hollingworth S, Duncan EL, Martin JH. Marked increase- in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf 2010; 19:1019-24.
46. Singh P, Arrevad PS, Peterson GM, Bereznicki LR. Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities. J Clin Pharm Ther 2011; 36:166-71.
47. Otmar R, Henry MJ, Kotowicz MA, Nicholson GC, Korn S, Pasco JA. Patterns of treatment in Australian men following fracture. Osteoporosis hit 2011; 22: 249-54.
48. Scott I, Jayathissa S. Quality of drug prescribing in older patients: Is there a problem and can we improve it? Intern Med J 2010; 40: 7-18.
49. Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29: 463-75.
50. Roberts GW, Farmer CJ, Cheney PC, Govis SM, Belcher TW, Walsh SA, el al. Clinical decision support implemented with academic detailing improves prescribing of key renally cleared drugs in the hospital setting. J Am Med Inform Assoc 2010; 17: 308-12.
51. Caughey GE, Roughead EE, Shakib S, McDermott RA, Vitry AI, Gilbert AL. Comorbidity of chronic disease and potential treatment conflicts in older people dispensed antidepressants. Age Ageing 2010; 39: 488-94.
52. Dolton MJ, Pont L, Stevens G, McLachlan AJ. Prevalence of potentially harmful drug interactions in older people in Australian aged-care facilities. J Pharm Pract Res 2012; 42: 33-6.
53. Hassan FA, Taylor DM, Leow FHP, Doolan G, Knott JC. Potential interactions between drugs taken by emergency department patients of an Australian hospital. J Pharm Pract Res 2006; 36: 266-70.
54. Roughead EE, McDermott B, Gilbert AL. Anbdepressants: prevalence of duplicate therapy and avoidable drug interactions in Australian veterans. Aust NZ J Psychiatry 2007; 41: 366-70.
55. Roughead EE, Kalisch LM, Barratt JD, Gilbert AL. Prevalence of potentially hazardous drug interactions amongst Australian veterans. Br J Clin Pharmacol 2010; 70: 252-7.
56. Roughead EE, Kalisch LM, Pratt NL, Killer G, Barnard A, Gilbert AL. Managing glaucoma in those with co-morbidity: not as easy as it seems. Ophthalmic Epidemiol 2012; 19: 74-82.
57. Vitry At, Roughead EE, Ramsay EN, Preiss AK, Ryan P, Gilbert AL, el at. Major bleeding risk associated with warfarin and co-medications in the elderly population. Pharmacoepidemiol Drug Sof 2011; 20: 1057-63.
58. Caughey GE, Roughead EE, Shakib S, Vitry AI, Gilbert AL. Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data. Drugs Aging 2011; 28: 575-81.
59. Elliott RA, Marriott JL. Standardised assessment of patients' capacity to manage medications: a systematic review of published instruments. BMC Ceriatr 2009; 9: 27.
60. Ingersoll KS, Cohen ]. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008; 31: 213-24.
61. Coleman CI, Limone B, Sobieraj DM, Lee S, Roberts MS, Kaur R, el at. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm 2012; 18: 527-39.
62. Kripalani S, Yao X, Haynes RB. Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 2007; 167: 540-50.
63. Richter A, Anton SF, Koch P, Dennett SL. The impact of reducing dose frequency on health outcomes. Clin Ther 2003; 25: 2307-35.
64. Elliott RA. Reducing medication regimen complexity for older patients prior to discharge from hospital: feasibility and barriers. J Clin Pharm Ther 2012; 37: 637-42.
65. Manias E, Claydon-Platt K, McColl GJ, Bucknall TK, Brand CA. Managing complex medication regimens: perspectives of consumers with osteoarthritis and healthcare professionals. Ann Pharinacother 2007; 41:764-71.
66. Steinman MA, Handler SM, Gurwitz JH, Schiff GD, Covinsky KE. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Ceriatr Soc 2011; 59: 1513-20.
67. Nishtala PS, McLachlan AJ, Bell JS, Chen TF. A retrospective study of drug-related problems in Australian aged care homes: medication reviews involving pharmacists and general practitioners. J Eval Clin Pract 2011; 17:97-103.
68. Pit SW, Byles JE, Cockburn J. Medication review: patient selection and general practitioner's report of drug-related problems and actions taken in elderly Australians. I Am Ceriatr Soc 2007; 55:927-34.
69. Berecki-Gisolf J, Hockey R, Dobson A. Adherence to bisphosphonate treatment by elderly women. Menopause 2008; 15: 984-90.
70. Roughead EE, Ramsay E, Priess K, Barratt J, Ryan P, Gilbert AL. Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates. Pharmacoepidemiol Drug Saf 2009; 18: 69-75.
71. Roughead EE, Vitry Al, Preiss AK, Barratt JD, Gilbert AL, Ryan P. Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease. Eur J Cardiovasc Prev Rehab 2010; 17: 71-6.
72. Simons LA, Ortiz M, Calcino G. Persistence with antihypertensive medication: Australia-wide experience, 2004-2006. Med J Aust 2008; 188: 224-7.
73. Simons LA, Ortiz M, Calcino G. Long term persistence with statin therapy ~ experience in Australia 2006-2010. Aust Fam Physician 2011; 40: 319-22.
74. Caughey GE, Preiss AK, Vitry AI, Gilbert AL, Ryan P, Shakib S, et al. Does antidepressant medication use affect persistence with diabetes medicines? Pharmacoepidemiol Drug Snf 2013; 22: 615-22.
75. Doggrell SA, Kairuz T. Medicines management by the older-aged living independently in different types of retirement villages. J Pharm Pract Res 2012; 42: 208-12.
76. Doggrell SA. Inadequate management of medicines by the older-aged living in a retirement village, Int J Clin Pharm 2013; 35: 546-9.
77. Douglas A, Letts L, Richardson J. A systematic review of accidental injury from fire, wandering and medication self-administration errors for older adults with and without dementia. Arch Gerontol Geriatr 2011; 52: el-10.
78. Claydon-Platt K, Manias E, Dunning T. Medical ion-related problems occurring in people with diabetes during an admission to an adult teaching hospital: a retrospective cohort study. Diabetes Res Clin Pract 2012; 97: 223-30.
79. Pit SW, Byles JE, Cockburn J. Prevalence of self-reported risk factors for medication misadventure among older people in general practice. J Eval Clin Pract 2008; 14: 203-8.
80. Ellis JC, Mullan J, Worsley T. Prescription medication hoarding and borrowing or sharing behaviours in older residents in the Qlawarra, New South Wales, Australia. Australas J Ageing 2011; 30:119-23.
81. Guirguis K. Medications collected for disposal by outreach pharmacists in Australia. Pharm World SCi 2010; 32: 52-8.
82. Vuong T, Marriott JL. Unnecessary medicines stored in homes of patients at risk of medication misadventure. J Pharm Pract Res 2006; 36: 16-20.
83. Gilmartin JF-M, Hussainy SY, Marriott IL. Medicines in Australian nursing homes: a cross-sectional observational study of the accuracy and suitability of re-packing medicines into pharmacy-supplied dose administration aids. Res Social Adtn Pharm 2013; 9:876-S3.
84. Carruthers A, Naughton K, Mallarkey G. Accuracy of packaging of dose administration aids in regional aged care facilities in the 1 lunter area of New South Wales. Med J Aust 2008; 188: 280-2.
85. Alderman CP, Kong L, Kildea L. Medication-related problems identified in home medicines reviews conducted in an Australian rural setting. Consult Pharm 2013; 28: 432-42.
86. Castelino RL, Bajorek BV, Chen TF. Are interventions recommended by pharmacists during Flome Medicines Review evidence-based? J Eval Clin Pract 2011; 17: 104-10.
87. Sta fford AC, Tenni PC, Peterson GM, Jackson SL, Hejlesen A, Villesen C, et at. Drug-related problems identified in medication reviews by Australian pharmacists. Pharm World Set 2009; 31: 216-23.
88. Tan ECK, Stewart K, Elliott RA, George J. Pharmacist consultations in general practice clinics: The Pharmacists in Practice Study (PIPS). Res Social Adtn Pharm 2014; 10: 623-32.
89. Vuong T, Marriott JL, Kong DCM, Siderov J. Implementation of a community liaison pharmacy service: a randomised controlled trial. tnt I Pharm Pract 2008, 16: 127-35
90. Castelino RL, Bajorek BV, Chen TF. Retrospective evaluation of home medicines review by pharmacists in older Australian patients using the medication appropriateness index. Ann Pharmacother 2010; 44: 1922-9.
91. Zhang M, Holman CDAJ, Preen DB, Brameld K. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol 2007; 63: 163-70.
92. Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006; 184: 321-1.
93. Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Cumming RG, Handelsman DJ, el al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Titer 2012; 91:521-8.
94. Best O, Gnjidic D, Flilmer SN, Naganathan V, McLachlan AJ. Investigating polypharmacy and drug burden index in hospitalised older people. Intern Med J 2013; 43: 912-918.
95. Caughey GE, Roughead EE, Pratt N, Shakib S, Vitry AL, Gilbert AL. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf 2010; 19: 977-82.
96. Pratt N, Roughead EE, Ramsay E, Salter A, Ryan P. Risk of hospitalization for hip fracture and pneumonia associated with antipsychotic prescribing in the elderly: a self-controlled case-series analysis in an Australian health care claims database. Drug Saf 2011; 34: 567-75.
97. Roughead EE, Ramsay EN, Pratt NL, Ryan P, Gilbert AL. Proton-pump inhibitors and the risk of antibiotic use and hospitalisation for pneumonia. Med J Aust 2009; 190: 114-16.
98. Leach M, Pratt N, Roughead EE. Medicine use among older Australians before and after hip fracture. J Pharm Pract Res 2013; 43: 265-8.
99. Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs, hit I Legal Med 2011; 125: 803-15.
100. Australian Commission on Safety and Quality in Health Care. Literature Review: Medication Safety in Australia; 2013. Available from . Accessed 14 November 2014.
101. Phillips AL, Nigro O, Macolino KA, Scarborough KC, Doecke CJ, Angley MT, et al. Hospital admissions caused by adverse drug events: an Australian prospective study. Aust Health Rev 2014; 38: 51-7.
102. Kalisch LM, Caughey GE, Barratt JD, Ramsay EN, Killer G, Gilbert AL, et al. Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm. Int I Qual Health Care 2012; 24: 239-49.
103. Zhang M, Holman CDAJ, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009; 338: a2752.
104. Parsons C, Lapane K, Kerse N, Hughes C. Prescribing for older people in nursing homes: a review of the key issues. Int} Older People Nurs 2011; 6: 45-54.
105. Hines LE, Murphy JE. Potentially harmful drug-drug interactions in the elderly: a review. Am J Geriatr Pharmacother 2011; 9: 364-77.
106. Permpongkosol S. Iatrogenic disease in the elderly: risk factors, consequences, and prevention. Clin Intent Aging 2011; 6: 77-82.
107. Bell JS, Kalisch LM, Ramsay EN, Pratt NL, Barratt JD, LeBlanc T, et al Prescriber feedback to improve quality use of medicines among older people: the veterans' mates program. J Pharm Pract Res 2011; 41:316-19.
108. Roughead EE, Kalisch LM, Ramsay EN, Ryan P, Gilbert AL. Continuity of care: when do patients visit community healthcare providers after leaving hospital? Intern Med j 2011; 41: 662-7.
109. Lee CY, George J, Elliott RA, Chapman CB, Stewart K. Exploring medication risk among older residents in supported residential services: a cross-sectional study. J Pharm Pract Res 2011; 41: 98-101.
110. Huyn K, Erny-Albrecht K, McTntyre E. Primary I lealth Care Research Information Service. Home Medicine Reviews: recent changes and potential implications. PHCRIS Research Roundup. 2014; Issue 39. Available from . Accessed 14 November 2014.
111. Snowdon J, Galanos D, Vaswani D. Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. Int Psychogeriatr 2011; 23: 1520-5.
112. Westbury JL, Jackson S, Peterson GM. Psycholeptic use in aged care homes in Tasmania, Australia. I Clin Pharm Ther 2010; 35:189-93.
113. Elliott RA, Thomson WA. Assessment of a nursing home medication review service provided by hospital-based clinical pharmacists. Aust ] Hosp Pharm 1999; 29: 255-60.
114. Tan ECK, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm 2014; 10: 608-22.
115. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Pail 2009; 2:424-8.
116. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Feck R, et al. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther 2011; 36: 27-32.
117. Pit SW, Byles JE, Henry DA, Holt L, Hansen V, Bowman DA. A quality use of medicines program for general practitioners and older people: a cluster randomised controlled trial. Med J Aust 2007; 187: 23-30.
118. Semple S, Roughead E. Medication safety in acute care in Australia: where are we now? Part 2: A review of strategies and activities for improving medication safety 2002-2008. Aust NZ Health Policy 2009; 6: 24.
119. Smith AJ, Tett SE. How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003-6. Drugs Aging 2009; 26: 113-22.
120. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br I Clin Pharmacol 2014; 78: 738-47.